Anopheles mosquito: vector of the parasite causing malaria in humansThe world’s first malaria vaccine, produced by GlaxoSmithKline, could be approved by international regulators for use in Africa from October.
The final trial data showed that the shoe, called RTS, S offered partial protection for children for up to four years.
It will be the first licensed human vaccine against a parasitic disease, and could help prevent millions of cases of malaria, which currently kills more than 600,000 people a year.
Experts have long hoped scientists would be able to develop an effective malaria vaccine, and researchers at the British drug maker, GSK, have …Read More
Source:: PM Newspaper
